Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viviana Meraviglia

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Cardiovascular Medicine|January 6, 2022
Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?Viviana Meraviglia, Mireia Alcalde, Oscar Campuzano, et al.
Cells|August 8, 2014
microRNAs and Cardiac Cell FateChiara Piubelli, Viviana Meraviglia, Giulio Pompilio, et al.
Stem Cell Research|June 16, 2021
Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutationViviana Meraviglia, Sravya Ganesh, Christiaan H Arendzen, et al.
Stem Cell Research|April 22, 2020
Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 geneViviana Meraviglia, Christiaan H Arendzen, Christian Freund, et al.
Stem Cell Research|June 3, 2020
Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutationViviana Meraviglia, Christiaan H Arendzen, Merve Tok, et al.
Frontiers in Cardiovascular Medicine|June 13, 2022
Toward Human Models of Cardiorenal Syndrome <i>in vitro</i>Beatrice Gabbin, Viviana Meraviglia, Christine L Mummery, et al.
Scientific Reports|September 27, 2023
Patient-specific primary and pluripotent stem cell-derived stromal cells recapitulate key aspects of arrhythmogenic cardiomyopathyAngela Serena Maione, Viviana Meraviglia, Lara Iengo, et al.
Nature Protocols|March 27, 2021
Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cellsGiulia Campostrini, Viviana Meraviglia, Elisa Giacomelli, et al.
BMC Genomics|June 27, 2018
The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cellsJohannes Rainer, Viviana Meraviglia, Hagen Blankenburg, et al.
Plos One|September 19, 2014
Syngeneic cardiac and bone marrow stromal cells display tissue-specific microRNA signatures and microRNA subsets restricted to diverse differentiation processesViviana Meraviglia, Valerio Azzimato, Luca Piacentini, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Cardiovascular Medicine|January 6, 2022
Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?Viviana Meraviglia, Mireia Alcalde, Oscar Campuzano, et al.
Cells|August 8, 2014
microRNAs and Cardiac Cell FateChiara Piubelli, Viviana Meraviglia, Giulio Pompilio, et al.
Stem Cell Research|June 16, 2021
Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutationViviana Meraviglia, Sravya Ganesh, Christiaan H Arendzen, et al.
Stem Cell Research|April 22, 2020
Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 geneViviana Meraviglia, Christiaan H Arendzen, Christian Freund, et al.
Stem Cell Research|June 3, 2020
Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutationViviana Meraviglia, Christiaan H Arendzen, Merve Tok, et al.
Frontiers in Cardiovascular Medicine|June 13, 2022
Toward Human Models of Cardiorenal Syndrome <i>in vitro</i>Beatrice Gabbin, Viviana Meraviglia, Christine L Mummery, et al.
Scientific Reports|September 27, 2023
Patient-specific primary and pluripotent stem cell-derived stromal cells recapitulate key aspects of arrhythmogenic cardiomyopathyAngela Serena Maione, Viviana Meraviglia, Lara Iengo, et al.
Nature Protocols|March 27, 2021
Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cellsGiulia Campostrini, Viviana Meraviglia, Elisa Giacomelli, et al.
BMC Genomics|June 27, 2018
The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cellsJohannes Rainer, Viviana Meraviglia, Hagen Blankenburg, et al.
Plos One|September 19, 2014
Syngeneic cardiac and bone marrow stromal cells display tissue-specific microRNA signatures and microRNA subsets restricted to diverse differentiation processesViviana Meraviglia, Valerio Azzimato, Luca Piacentini, et al.
Pageof 4